LeonaBio (LONA) Depreciation & Amortization (CF) (2020 - 2026)
LeonaBio's (LONA) quarterly Depreciation & Amortization (CF) came in at $231000.0 in Q1 2026, down 4.94% year-on-year from $243000.0 in Q1 2025, and down 23.0% on a QoQ basis from $300000.0 in Q4 2025.
LeonaBio (LONA) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
LeonaBio (LONA) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $231000.0 in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 4.94% year-over-year to $231000.0 in Q1 2026; TTM through Mar 2026 was $931000.0, a 1.97% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, up 3.09% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $231000.0, down from $300000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for LONA reached as high as $300000.0 in Q4 2025 and fell as low as $154000.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $229411.8 across 5 years, with a median of $236000.0 in 2023.
- Across the five-year window, Depreciation & Amortization (CF) jumped 89.68% in 2022 and retreated 18.03% in 2024, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $239000.0 in 2022, then grew by 2.51% to $245000.0 in 2023, then increased by 10.2% to $270000.0 in 2024, then advanced by 11.11% to $300000.0 in 2025, then fell by 23.0% to $231000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $231000.0 in Q1 2026, $300000.0 in Q4 2025, and $200000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - | 231,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231,000.00 |
| Mar 31, 2026 | 231,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 243,000.00 |
| Mar 31, 2025 | 243,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 242,000.00 |
| Mar 31, 2024 | 242,000.00 |
| Dec 31, 2023 | 245,000.00 |
| Dec 31, 2023 | 245,000.00 |